DSGN - Design Therapeutics Board Member Makes $5.37M Stock Purchase | Benzinga
Arsani William, Board Member at Design Therapeutics (NASDAQ:DSGN), reported a large insider buy on August 30, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that William purchased 2,235,000 shares of Design Therapeutics. The total transaction amounted to $5,373,650.
Design Therapeutics shares are trading up 4.96% at $2.44 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to ...